NANOVIRICIDES, INC. Cash and Restricted Cash
NANOVIRICIDES, INC. (NNVC) had Cash and Restricted Cash of $3.21 million as of 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-05-15
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $3.21M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $5.15M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1.13M.
- 2025-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1.56M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-03-31 | $3.21M 10-Q · filed 2026-05-15 |
| 2025-12-31 | $5.15M 10-Q · filed 2026-02-17 |
| 2025-09-30 | $1.13M 10-Q · filed 2025-11-14 |
| 2025-06-30 | $1.56M 10-Q · filed 2026-05-15 |
| 2025-03-31 | $2.54M 10-Q · filed 2026-05-15 |
| 2024-12-31 | $3.96M 10-Q · filed 2026-02-17 |
| 2024-09-30 | $3.87M 10-Q · filed 2025-11-14 |
| 2024-06-30 | $4.80M 10-Q · filed 2026-05-15 |
| 2024-03-31 | $3.26M 10-Q · filed 2025-05-15 |
| 2023-12-31 | $5.25M 10-Q · filed 2025-02-14 |
| 2023-09-30 | $6.97M 10-Q · filed 2024-11-14 |
| 2023-06-30 | $8.15M 10-K · filed 2025-09-29 |
| 2023-03-31 | $9.65M 10-Q · filed 2024-05-15 |
| 2022-12-31 | $11.45M 10-Q · filed 2024-02-14 |
| 2022-09-30 | $12.92M 10-Q · filed 2023-11-14 |
| 2022-06-30 | $14.07M 10-K · filed 2024-09-27 |
| 2022-03-31 | $15.57M 10-Q · filed 2023-05-15 |
| 2021-12-31 | $17.34M 10-Q · filed 2023-02-14 |
| 2021-09-30 | $19.70M 10-Q · filed 2022-11-14 |
| 2021-06-30 | $20.52M 10-K · filed 2023-10-13 |
| 2021-03-31 | $22.90M 10-Q · filed 2022-05-16 |
| 2020-12-31 | $18.39M 10-Q · filed 2022-02-14 |
| 2020-09-30 | $21.79M 10-Q · filed 2021-11-15 |
| 2020-06-30 | $13.71M 10-K · filed 2022-10-13 |
| 2020-03-31 | $6.11M 10-Q · filed 2021-05-14 |
| 2019-12-31 | $707.65K 10-Q · filed 2021-02-16 |
| 2019-09-30 | $874.95K 10-Q · filed 2020-11-16 |
| 2019-06-30 | $2.56M 10-K · filed 2021-10-12 |
| 2019-03-31 | $4.24M 10-Q · filed 2020-06-22 |
| 2018-12-31 | $3.90M 10-Q · filed 2020-02-14 |
| 2018-09-30 | $6.08M 10-Q · filed 2019-11-15 |
| 2018-06-30 | $7.08M 10-K · filed 2021-10-12 |
| 2017-06-30 | $15.10M 10-K · filed 2020-10-13 |
| 2016-06-30 | $24.16M 10-K · filed 2019-08-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |